聚合物偶联 IL-15 NKTR-255 与 CAR-T 细胞治疗协同激活内源性抗肿瘤免疫并改善肿瘤控制 NKTR-255, a polymer-conjugated IL-15, synergizes with CAR-T cell therapy to activate endogenous anti-tumor immunity and improve tumor control. PubMed 2025/12/15 发表bioRxiv 靶点:CD19靶点:ROR1技术:CAR-T技术:NK 细胞肺癌B 细胞恶性肿瘤
临床前研究中开发靶向 ROR1 的 CAR-T 细胞抗实体瘤 Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical Studies. PubMed 2022/07/25 发表Cancers (Basel)Q2 · IF 4.8(JCR 2025) 靶点:ROR1技术:CAR-TB 细胞恶性肿瘤实体瘤地区:中国